0001415889-24-012328.txt : 20240506 0001415889-24-012328.hdr.sgml : 20240506 20240506163013 ACCESSION NUMBER: 0001415889-24-012328 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240503 FILED AS OF DATE: 20240506 DATE AS OF CHANGE: 20240506 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SULLIVAN LOUIS W CENTRAL INDEX KEY: 0001193522 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 24917984 FORMER NAME: FORMER CONFORMED NAME: SULLIVAN LOUIS DATE OF NAME CHANGE: 20020927 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1000 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 form4-05062024_040501.xml X0508 4 2024-05-03 0001082554 UNITED THERAPEUTICS Corp UTHR 0001193522 SULLIVAN LOUIS W C/O UNITED THERAPEUTICS CORPORATION 1000 SPRING STREET SILVER SPRING MD 20910 true false false false 0 Common Stock 2024-05-03 4 M 0 5160 119.76 A 18220 D Common Stock 2024-05-03 4 S 0 2181 257.3895 D 16039 D Common Stock 2024-05-03 4 S 0 2979 259.1199 D 13060 D Stock Options 119.76 2024-05-03 4 M 0 5160 0 D 2021-06-26 2030-06-26 Common Stock 5160 0 D This transaction was executed in multiple trades at prices ranging from $256.98 to $257.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $258.49 to $259.395. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ John S. Hess, Jr. under Power of Attorney 2024-05-06